Allosteric cross-talk in chromatin can mediate drug-drug synergy.
about
Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.The Differential Distribution of RAPTA-T in Non-Invasive and Invasive Breast Cancer Cells Correlates with Its Anti-Invasive and Anti-Metastatic Effects.Nucleosome acidic patch-targeting binuclear ruthenium compounds induce aberrant chromatin condensation.Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.Pseudo electron-deficient organometallics: limited reactivity towards electron-donating ligands.
P2860
Allosteric cross-talk in chromatin can mediate drug-drug synergy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Allosteric cross-talk in chromatin can mediate drug-drug synergy.
@ast
Allosteric cross-talk in chromatin can mediate drug-drug synergy.
@en
type
label
Allosteric cross-talk in chromatin can mediate drug-drug synergy.
@ast
Allosteric cross-talk in chromatin can mediate drug-drug synergy.
@en
prefLabel
Allosteric cross-talk in chromatin can mediate drug-drug synergy.
@ast
Allosteric cross-talk in chromatin can mediate drug-drug synergy.
@en
P2093
P2860
P50
P356
P1476
Allosteric cross-talk in chromatin can mediate drug-drug synergy.
@en
P2093
Curt A Davey
Tina Riedel
Ursula Rothlisberger
Zenita Adhireksan
P2860
P2888
P356
10.1038/NCOMMS14860
P407
P577
2017-03-30T00:00:00Z
P6179
1084129043